Mark S. Ordan Appointed Chief Executive Officer, Succeeding Company Founder Roger J. Medel, M.D. Guy P. Sansone Appointed Chair of Board of Directors Significant Board Refreshment, With Five New Independent Directors Appointed to Succeed Five Departing Directors Company Reaches Agreement with Starboard Value FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jul. 13, 2020-- MEDNAX, Inc. (NYSE: MD), the nation`s leading provider of maternal-fetal, newborn and pediatric subspecialty care, today announced that the Company`s Board of Directors has appointed Mark S. Ordan as Chief Executive Officer, succeeding Roger J. Medel, M.D., the Company`s founder. Dr. Medel will remain a member of the Board until the...
|
